Lifemd Inc (LFMD) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Lifemd Inc   (NASDAQ: LFMD)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

Lifemd Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Lifemd Inc 's inventory turnover ratio, the ratio that measures Lifemd Inc 's ability to manage its supply chain, sequentially decreased to 7.22 in the second quarter 2026, but it does not raise any concerns as Lifemd Inc continue to execute well, and the inventory turnover ratio remains above the average. Lifemd Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 51 days, from 48 days, in the Mar 31 2026 quarter.

Within Healthcare sector 52 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 459 in the first quarter 2026, to 526.

LFMD Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Lifemd Inc Market Share?

What is Inventory Turnover Ratio?




LFMD Inventory Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Inventory Growth -9.08 % 7.06 % -0.85 % 29.75 % 57.78 %
Y / Y Cost of Sales Growth -24.51 % -37.5 % -50 % 40 % 40 %
Inventory Turnover Ratio (TTM) 7.22 7.6 8.69 10.28 10.29
LFMD's Total Ranking # 526 # 459 # 332 # 338 # 297
Average inventory processing period 51 48 42 35 35
Seq. Inventory Growth -6.96 % 14.55 % -19.19 % 5.57 % 9.56 %
Seq. Cost of Sales Growth 5.69 % 0 % -28.57 % 0 % -12.5 %




Inventory Turnover Ratio Company Ranking
Within: No.
Healthcare Facilities Industry # 12
Healthcare Sector # 53
Overall Market # 526

Inventory Turnover Ratio Statistics
High Average Low
23.21 6.67 -0.83
(Mar 31 2016)   (Jun 30 2017)




Financial Statements
Lifemd Inc 's Inventories $ 3 Millions Visit LFMD's Balance sheet
Lifemd Inc 's Cost of Revenues TTM $ 22 Millions Visit LFMD's Income Statement
What are LFMD's Sales? Visit LFMD's Sales by Segment

Other Inventory Turnover Ratios
Lifemd Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Healthcare Facilities Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
LFMD's Inventory Turnover Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for LFMD's Competitors
Inventory Turnover Ratio for LFMD's Suppliers
Inventory Turnover Ratio for LFMD's Customers

You may also want to know
LFMD's Sales Growth Rates LFMD's Pe Price to earnings ratio LFMD's Receivables Turnover Ratio LFMD's Stock Quote
LFMD's Net Income Growth Rates LFMD's Ps Price to Sales ratio LFMD's Sales per Employee LFMD's Asset Turnover Ratio
LFMD's Net Margin LFMD's Pb Price to Book ratio LFMD's Financial Strength Ratios LFMD's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Sbc Medical Group Holdings Incorporated  19.68 $ 48.095  Millions$ 2  Millions
Adapthealth Corp   19.31 $ 2,552.376  Millions$ 132  Millions
Labcorp Holdings Inc   19.29 $ 10,203.900  Millions$ 529  Millions
Aspira Women s Health inc   19.13 $ 5.073  Millions$ 0  Millions
Precipio inc   18.05 $ 15.200  Millions$ 1  Millions
Rockwell Medical inc   17.36 $ 57.537  Millions$ 3  Millions
Neuronetics Inc   16.61 $ 78.345  Millions$ 5  Millions
Cryo cell International Inc   15.87 $ 6.869  Millions$ 0  Millions
Rosecliff Acquisition Corp I  14.94 $ 9.597  Millions$ 1  Millions
Catheter Precision Inc   14.83 $ 1.001  Millions$ 0  Millions
Agape Atp Corporation  14.52 $ 0.413  Millions$ 0  Millions
Celularity Inc   13.93 $ 15.077  Millions$ 1  Millions
Earth Science Tech Inc   11.64 $ 8.974  Millions$ 1  Millions
Alnylam Pharmaceuticals Inc   11.45 $ 970.735  Millions$ 85  Millions
Infusystem Holdings Inc  10.92 $ 60.985  Millions$ 6  Millions
Option Care Health Inc   10.83 $ 4,607.869  Millions$ 426  Millions
Irhythm Holdings Inc   10.79 $ 235.967  Millions$ 22  Millions
Genedx Holdings Corp   10.27 $ 140.202  Millions$ 14  Millions
Tarsus Pharmaceuticals Inc   10.20 $ 43.740  Millions$ 4  Millions
Lantheus Holdings Inc   10.09 $ 619.325  Millions$ 61  Millions
Sotera Health Company  10.04 $ 547.412  Millions$ 55  Millions
Natera Inc   9.46 $ 672.186  Millions$ 71  Millions
Warby Parker Inc   9.27 $ 414.054  Millions$ 45  Millions
Hims and Hers Health Inc   9.23 $ 814.411  Millions$ 88  Millions
Zevra Therapeutics Inc   9.09 $ 17.880  Millions$ 2  Millions
Polomar Health Services, Inc.  8.80 $ 1.233  Millions$ 0  Millions
Myriad Genetics Inc   8.31 $ 250.700  Millions$ 30  Millions
National Vision Holdings Inc   8.26 $ 841.416  Millions$ 102  Millions
Castle Biosciences Inc   8.14 $ 81.252  Millions$ 10  Millions
Autolus Therapeutics Plc  8.08 $ 99.009  Millions$ 12  Millions

Date modified: 2026-10-05T11:03:41+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.